Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  London Stock Exchange  >  Vernalis plc    VER   GB00B3Y5L754

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Vernalis plc
Researches and develops pharmaceutical products

Vernalis Plc engages in the research, development, and commercialization of pharmaceutical products under the Tuzistra XR brand.

The company was founded by Keith G. McCullagh in 1986 and is headquartered in Winnersh, United Kingdom.

Number of employees : 103 persons.
Sales per Businesses
20152016Delta
GBP (in Million)%GBP (in Million)%
Pharmaceuticals13.26100%---
Research & Development--8.0466.8%-
Commercial--3.9933.2%-
Sales per Regions
20152016Delta
GBP (in Million)%GBP (in Million)%
Rest of Europe10.2577.4%8.1367.6% -20.68%
Rest of the World2.3217.5%2.7322.7% +18%
North America0.6695%1.169.7% +73.69%
United Kingdom0.0160.1%0.0050% -68.75%
Managers
NameAgeSinceTitle
Ian Garland51-Chief Executive Officer & Executive Director
Sandford Sommer-2016President & Chief Operating Officer
Peter John Fellner, PhD742003Non-Executive Chairman
David MacKney49-Chief Financial Officer & Executive Director
Pascal Borderies, MD-2014Senior Vice President-Medical Affairs
Carol C. Ferguson702003Senior Independent Non-Executive Director
Nigel Sheail512011Independent Non-Executive Director
Ian David Gilham, PhD572015Independent Non-Executive Director
Lisa Amster Schoenberg, MBA502015Non-Executive Director
Kevin Kissane612010Secretary & General Counsel
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 526,352,521 520,442,829 98.9% 0 0.0% 98.9%
Shareholders
NameEquities%
Invesco Asset Management Ltd. 194,441,770 36.9%
Woodford Investment Management LLP 157,226,138 29.9%
GAM London Ltd. 47,861,787 9.09%
Legal & General Investment Management Ltd. 30,642,580 5.82%
Aviva Investors Global Services Ltd. 26,309,928 5.00%
Rothschild Bank AG 12,129,000 2.30%
Majedie Asset Management Ltd. 8,179,958 1.55%
EdenTree Investment Management Ltd. 4,750,000 0.90%
River & Mercantile Asset Management LLP 3,008,987 0.57%
Hargreaves Lansdown Asset Management Ltd. 2,912,000 0.55%
Sector
Healthcare
Pharmaceuticals & Medical Research
 Biotechnology & Medical Research
  Biotechnology & Medical Research
   Biotechnology & Medical Research - NEC
Advertisement
Sector Biotechnology & Medical Research - NEC
1st jan.Capitalization (M$)
VERNALIS PLC-25.00%167
INCYTE CORPORATION30.86%25 385
QUINTILES IMS HOLDINGS..2.09%18 749
CELLTRION, INC.--.--%10 997
LONZA GROUP AG2.04%10 407
SEATTLE GENETICS, INC.18.87%9 393
ALKERMES PLC-4.68%8 451
UNITED THERAPEUTICS CO..2.29%6 857
QIAGEN NV-3.29%6 634
IONIS PHARMACEUTICALS ..-6.77%5 684
ACADIA PHARMACEUTICALS..34.81%4 826
ICON PLC11.70%4 744
ALNYLAM PHARMACEUTICAL..24.52%4 413
CHARLES RIVER LABORATO..15.57%4 242
BIO-TECHNE CORP3.66%4 009
PRA HEALTH SCIENCES IN..9.18%3 762
PAREXEL INTERNATIONAL ..0.33%3 376
GALAPAGOS6.43%3 207
BB BIOTECH AG2.90%3 173
INC RESEARCH HOLDINGS ..4.66%3 032
INTREXON CORP-9.84%2 723
Sector Biotechnology & Medical Research - NEC
Vernalis plc : Connections
Biosurfit SA
The Institute of Chartered Accountants of Scotland
Multiplicom NV
Concepta Diagnostics Ltd.
Chartered Accountants Compensation Scheme Ltd.
Stowheath Ltd.
Company contact information
Vernalis Plc
100 Berkshire Place
Wharfedale Road
Winnersh, Berkshire RG41 5RD

Phone : +44.118.938.0000
Fax : +44.118.938.0001
Web : www.vernalis.com
© 2017 People , Fundamentals and Ownership